Treace Medical Concepts, Inc.
General ticker "TMCI" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $453.7M (TTM average)
Treace Medical Concepts, Inc. does not follow the US Stock Market performance with the rate: -7.8%.
Estimated limits based on current volatility of 4.0%: low 2.69$, high 2.91$
Factors to consider:
- Total employees count: 477 (-7.6%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Reimbursement risks affecting product adoption, Market competition, Uncertain profitability, Operational and conduct risks, Cybersecurity threats
- Current price 23.8% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [3.59$, 9.68$]
- 2025-12-31 to 2026-12-31 estimated range: [3.66$, 9.67$]
Financial Metrics affecting the TMCI estimates:
- Negative: with PPE of -7.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.53 <= 0.33
- Positive: Investing cash flow per share per price, % of 8.12 > -0.66
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Negative: negative Industry operating cash flow (median)
- Positive: 41.86 < Shareholder equity ratio, % of 52.00 <= 63.39
- Negative: negative Net income
Short-term TMCI quotes
Long-term TMCI plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $141.84MM | $187.12MM | $209.36MM |
| Operating Expenses | $176.68MM | $238.55MM | $265.05MM |
| Operating Income | $-34.84MM | $-51.43MM | $-55.69MM |
| Non-Operating Income | $-7.97MM | $1.90MM | $-0.06MM |
| Interest Expense | $4.40MM | $5.17MM | $5.26MM |
| R&D Expense | $13.58MM | $15.44MM | $20.59MM |
| Income(Loss) | $-42.81MM | $-49.53MM | $-55.74MM |
| Profit(Loss)* | $-42.81MM | $-49.53MM | $-55.74MM |
| Stockholders Equity | $60.53MM | $137.94MM | $112.89MM |
| Inventory | $19.33MM | $29.25MM | $39.26MM |
| Assets | $159.02MM | $251.91MM | $217.09MM |
| Operating Cash Flow | $-30.65MM | $-34.58MM | $-37.17MM |
| Capital expenditure | $14.84MM | $11.46MM | $11.59MM |
| Investing Cash Flow | $-76.52MM | $-81.30MM | $35.38MM |
| Financing Cash Flow | $20.81MM | $109.38MM | $0.16MM |
| Earnings Per Share** | $-0.77 | $-0.81 | $-0.90 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.